Rockwell Medical (STU:RWM) Other Stockholders Equity: €-0.00 Mil (As of Mar. 2026)


STU:RWM Rockwell Medical Inc STU:RWM
26 GF Score
Price €4.80
GF Value €0.82
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Rockwell Medical Other Stockholders Equity?

Rockwell Medical STU:RWM 26 Other Stockholders Equity is €-0.00 Mil as of Mar. 2026. GuruFocus rates STU:RWM with a GF Score™ of 26/100 and a GF Value™ of €0.82 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Rockwell Medical's Other Stockholders Equity for the quarter that ended in Mar. 2026 was €-0.00 Mil.

Rockwell Medical's quarterly Other Stockholders Equity declined from Sep. 2025 (€0.00 Mil) to Dec. 2025 (€-0.00 Mil) but then increased from Dec. 2025 (€-0.00 Mil) to Mar. 2026 (€-0.00 Mil).

Rockwell Medical's annual Other Stockholders Equity declined from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€-0.00 Mil) but then increased from Dec. 2024 (€-0.00 Mil) to Dec. 2025 (€-0.00 Mil).

Rockwell Medical Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Rockwell Medical's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rockwell Medical Other Stockholders Equity Chart

Rockwell Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 0.00 -0.00 -0.00

Rockwell Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.00 -0.00
STU:RWM
26GF Score
Rockwell Medical Inc STU:RWM
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rockwell Medical Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-0.00 Mil mean?
Rockwell Medical (STU:RWM) has a Other Stockholders Equity of €-0.00 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Rockwell Medical and its competitors.
Is Rockwell Medical's Other Stockholders Equity too high?
Rockwell Medical's current Other Stockholders Equity is €-0.00 Mil. Overall, Rockwell Medical has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rockwell Medical's Other Stockholders Equity compare to CPHI and TXMD?
Rockwell Medical's Other Stockholders Equity of €-0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Drug Manufacturers company?
A good Other Stockholders Equity depends on the Drug Manufacturers industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Rockwell Medical and its competitors. Rockwell Medical's current Other Stockholders Equity is €-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rockwell Medical stock overvalued right now?
Based on GuruFocus' analysis, Rockwell Medical (STU:RWM) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.82, compared to a current price of €4.80 — trading 485.4% above its estimated fair value. The current Other Stockholders Equity is €-0.00 Mil. Rockwell Medical's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Rockwell Medical (STU:RWM), the current Other Stockholders Equity is €-0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rockwell Medical (STU:RWM) Overvalued in 2026?

Based on GuruFocus' analysis, Rockwell Medical stock appears to be overvalued. The current stock price of €4.80 is trading 485.4% above its estimated GF Value™ of €0.82. GuruFocus considers Rockwell Medical to be Significantly Overvalued.

Key valuation signals for STU:RWM:

  • Other Stockholders Equity: €-0.00 Mil
  • GF Value™: €0.82 vs. price of €4.80 (485.4% above fair value)
  • GF Score™: 26/100 with 3 warning signs

No single metric tells the full story. See the STU:RWM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rockwell Medical Business Description

Other Exchanges RMTI:USARWMA:Germany
Address 30142 South Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
26GF Score

Get the complete analysis for STU:RWM

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.80
Price
€0.82
GF Value